Neurogene Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neurogene Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Neurogene Inc. Return On Equity for the quarter ending September 30, 2024 was -25.9 %, a 185% decline year-over-year.
  • Neurogene Inc. annual Return On Equity for 2023 was 44.9 %.
  • Neurogene Inc. annual Return On Equity for 2022 was -107 %, a 79.9% decline from 2021.
  • Neurogene Inc. annual Return On Equity for 2021 was -59.4 %, a 193% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 44.9 +152 Jan 1, 2023 Dec 31, 2023
2022 -107 -47.4 -79.9% Jan 1, 2022 Dec 31, 2022
2021 -59.4 -39.1 -193% Jan 1, 2021 Dec 31, 2021
2020 -20.3 +58.6 +74.3% Jan 1, 2020 Dec 31, 2020
2019 -78.8 -40.1 -103% Jan 1, 2019 Dec 31, 2019
2018 -38.8 +3.53 +8.35% Jan 1, 2018 Dec 31, 2018
2017 -42.3 -12.4 -41.3% Jan 1, 2017 Dec 31, 2017
2016 -29.9 +1.48 +4.71% Jan 1, 2016 Dec 31, 2016
2015 -31.4 +20.5 +39.5% Jan 1, 2015 Dec 31, 2015
2014 -51.9 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.